Most Clicked StoriesMore >


Otelixizumab doesn't preserve beta-cell function in new-onset diabetes

DiabetesPro SmartBrief | Jul 29, 2014

Data on patients with new-onset type 1 diabetes revealed that a low dose of otelixizumab (3.1 mg over eight days) was ineffective in maintaining pancreatic beta-cell function. The results appear in Diabetes Care. Medscape (free registration) (07/25)


Firm unveils new food analysis app for diabetes

DiabetesPro SmartBrief | Jul 28, 2014

ADA introduces new interim CEO

DiabetesPro SmartBrief | Jul 30, 2014

Herbs show efficacy in blocking diabetes enzyme

DiabetesPro SmartBrief | Jul 24, 2014

Study looks at improving hypoglycemia awareness in type 1 diabetes

DiabetesPro SmartBrief | Jul 24, 2014

Higher brown-fat rates may curb diabetes risk

DiabetesPro SmartBrief | Jul 25, 2014

Free-of-charge webcasts from the 61st Annual Postgraduate Course -- Now available with CME/CE credits!

DiabetesPro SmartBrief | Jul 25, 2014

Experts ID virus that may affect obesity, diabetes

DiabetesPro SmartBrief | Jul 29, 2014

Head, neck cancer risk higher in diabetes patients, study finds

DiabetesPro SmartBrief | Jul 25, 2014

Key enzyme tied to diabetes onset in animal study

DiabetesPro SmartBrief | Jul 30, 2014


Find DiabetesPro SmartBrief Issues by Date:



ADA News More >


Proud Partner of Million HeartsĀ®

DiabetesPro SmartBrief | Jul 31, 2014

Upcoming ADA and JDRF Research Symposium in Chicago

DiabetesPro SmartBrief | Jul 30, 2014

Continuing education for health care professionals who treat patients with diabetes

DiabetesPro SmartBrief | Jul 30, 2014

Self-assessment program on exercise and diabetes -- free CME/CE opportunity

DiabetesPro SmartBrief | Jul 29, 2014

Free American Diabetes Association Safe at School Toolkit

DiabetesPro SmartBrief | Jul 28, 2014




Sign up for DiabetesPro SmartBrief



Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more

Recent Poll view more polls


What type of continuing education opportunities do you participate in most?

Chart.